| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neurogene Inc. | Chief Scientific Officer | Common Stock | 20.8K | $315K | $15.15 | 14 May 2025 | Direct |
| Neurogene Inc. | Chief Scientific Officer | Employee Stock Option (Right to buy) | 42.9K | 26 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | 14 May 2025 | 1 | -$103K | 4 | Chief Scientific Officer | 15 May 2025, 16:43 |
| NGNE | Neurogene Inc. | 26 Mar 2025 | 2 | $0 | 4 | Chief Scientific Officer | 28 Mar 2025, 21:30 |
| NGNE | Neurogene Inc. | 13 Mar 2024 | 2 | $0 | 4 | Chief Scientific Officer | 14 Mar 2024, 20:51 |
| NGNE | Neurogene Inc. | 18 Dec 2023 | 0 | $0 | 3 | Chief Scientific Officer | 26 Dec 2023, 18:05 |